To identify or exclude possible common molecular mechanisms in these neoplasms, known factors of tumor development of both the GISTs and adenocarcinomas (c-KIT/PDGFRα mutations, EBV/MSI status) were cross-tested on both tumor types. Here, PDGFRA is linked to neoplasm.